Приказ основних података о документу
Mechanical properties and long-term stability of novel lipid formulations with simvastatin
Mehanička svojstva i dugotrajna stabilnost novih lipidnih formulacija sa simvastatinom
dc.creator | Ćetković, Zora | |
dc.creator | Vasiljević, Ivana | |
dc.creator | Cvijić, Sandra | |
dc.creator | Vasiljević, Dragana | |
dc.date.accessioned | 2023-03-24T13:15:47Z | |
dc.date.available | 2023-03-24T13:15:47Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4567 | |
dc.description.abstract | Mixing selected liquid SMEDDS with polymethacrylate polymers (Eudragit ®) led to solidification of the samples to form solid, ductile, transparent systems (1). The purpose of this study was to define mechanical properties and long-term stability of novel simvastatin- loaded SMEDDS-based drug delivery systems. SMEDDS-based formulations were prepared by adding liquid SMEDDS (10% oleoyl macrogol-6 glycerides and 90% caprylocaproyl macrogol-8 glycerides/macrogol-15-hydroxystearate, in 3 ratios: 1:1, 2:1 and 3:1) to Eudragit ® S100 or Eudragit ® S100/Eudragit ® L100 combination (in 1:1 ratio), until SMEDDS/polymer ratio 2:1 w/w was reached. SMEDDS-based formulations with simvastatin (SV) were prepared by dissolving SV (5%) into liquid SMEDDS and mixing with polymethacrylate polymers in the same ratio. Prepared formulations were evaluated in terms of their mechanical properties and long-term stability. The results indicated that the increase in the caprylocaproyl macrogol-8 glycerides concentration resulted in higher penetration force (F1 S100–F3 S100 = 5.83-7.22 N and F1 SL100-F3 SL100 = 4.20-5.99 N). However, addition of SV was negatively correlated with the hardness, i.e. samples with SV were softer in comparison to unloaded samples. Moreover, it was noticeable that formulations with Eudragit ® S100 had greater penetration force values compared to formulations containing Eudragit ® S100/Eudragit ® L100. After six months of storage at room and elevated temperature, only slight decrease in SV content (less than 5%) was observed in these samples. This study demonstrated that novel SMEDDS-based formulations with higher concentration of caprylocaproyl macrogol-8 glycerides and those with Eudragit ® S100 were more robust, which may further serve as a guide for formulating tailor-made formulations. | sr |
dc.description.abstract | Mešanje odabranih tečnih samomikroemulgujućih sistema (SMEDDS) sa kopolimerima metakrilne kiseline (Eudragit ® ) dovodi do očvršćavanja uzoraka i formiranja čvrstih, rastegljivih, transparentnih sistema (1). Cilj ovog rada je bio ispitivanje mehaničkih svojstva i dugotrajne stabilnosti novih lipidnih sistema sa simvastatinom (SV). Lipidne formulacije su izrađene mešanjem tečnih SMEDDS (10% oleoil makrogol-6 glicerida i 90% kaprilokaproil makrogol-8 glicerida/makrogol-15-hidroksistearat, u 3 odnosa: 1:1, 2:1 i 3:1) i Eudragit ® S100 ili kombinacije Eudragit ® S100/Eudragit ® L100 (u odnosu 1:1). Odnos SMEDDS/polimer bio je 2:1, m/m. Uzorci sa SV su izrađeni rastvaranjem SV (5%) u tečnim SMEDDS i mešanjem sa kopolimerima metakrilne kiseline u navedenom odnosu. Sprovedena su ispitivanja mehaničkih osobina i dugotrajne stabilnosti izrađenih lipidnih formulacija. Rezultati su pokazali da povećanje koncentracije kaprilokaproil makrogol-8 glicerida dovodi do povećanja vrednosti sile penetracije (F1 S100–F3 S100 = 5,83-7,22 N i F1 SL100-F3 SL100 = 4,20-5,99 N). Uzorci sa SV su bili mekši, u poređenju sa uzorcima bez lekovite supstance. Takođe, uočeno je da uzorci sa polimerom Eudragit ® S100 imaju već e vrednosti sile penetracije, u poređenju sa formulacijama koje sadrže kombinaciju Eudragit ® S100/Eudragit ® L100. Posle šest meseci skladištenja uzoraka na sobnoj i povišenoj temperaturi, sadržaj SV je neznatno smanjen (manje od 5%). Ova studija je pokazala da nove lipidne formulacije izrađene sa većom koncentracijom kaprilokaproil makrogol-8 glicerida i sa Eudragit ® S100 polimerom imaju veće vrednosti sile penetracije i prihvatljivu dugotrajnu stabilnost, što je od značaja za razvoj lipidnih formulacija željenih karakteristika. | sr |
dc.language.iso | sr | sr |
dc.language.iso | en | sr |
dc.publisher | Savez farmaceutskih udruženja Srbije (SFUS) | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS// | sr |
dc.rights | openAccess | sr |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | sr |
dc.title | Mechanical properties and long-term stability of novel lipid formulations with simvastatin | sr |
dc.title | Mehanička svojstva i dugotrajna stabilnost novih lipidnih formulacija sa simvastatinom | sr |
dc.type | conferenceObject | sr |
dc.rights.license | BY-SA | sr |
dc.citation.volume | 72 | |
dc.citation.issue | 4 suplement | |
dc.citation.spage | S396 | |
dc.citation.epage | S397 | |
dc.description.other | VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-15.10.2022. Beograd | sr |
dc.identifier.fulltext | http://farfar.pharmacy.bg.ac.rs/bitstream/id/12329/Mechanical_properties_and_pub_2022.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_4567 | |
dc.type.version | publishedVersion | sr |